• Contact Form
  • help@soleburystrat.com
  • Login
Logo2
  • Events
  • Companies
  • Blog
  • Service
    • Help with Credentials
Logo2
Sign in with LinkedIn
Request new Password.
Presenter Access
Unsupported Browser. Please use Google Chrome, Mozilla Firefox, or Microsoft Edge to submit meeting requests. Microsoft Internet Explorer is not supported due to its outdated JavaScript engine.
Categories & Filter
  • All Posts
  • {{ value.title }}
  • Clear Categories



  • Preamble [SYSTEM]
  • Fund & Investor Interest
  • Street Moves
  • Solebury Trout Updates
  • Market Commentary
  • IPO News
  • Expert Interactions
  • Banker Comments & Notes
  • Conference Snippet
  • Industry Snippets
  • Social Media
  • Solebury Trout Talks

  • SoftBank Plans to Invest Billions in Biotech Stocks
  • In search of 'household healthcare brands of the future,' Foresite Capital raises $969M to satiate a tech-heavy appetite
  • OrbiMed, biopharma's biggest investor, closes $3.5B in three new private funds
  • Broadridge 2021 EDGAR Filing Calendar
  • Interview with Juergen Horn, Invetx - Part of the Name Tag Series
  • Jean Kim left Deerfield.
  • Interview with Jonathan Solomon, BiomX - Part of the Nametag Series
  • Follow Solebury Trout’s life sciences account on Twitter at @ST_LifeSciences
  • Interview with Dale Chappell, Humanigen - Part of the Nametag Series
  • Interview with Jonathan Drachman, Neoleukin Therapeutics - Part of the Nametag Series
  • Christian Richard left Tekla Capital Management LLC and joined Samsara BioCapital as Head of Public Research
  • Eliana Merle joined UBS as Analyst
  • Interview with Brandi Roberts, Lineage Cell Therapeutics - Part of the Nametag Series
  • Interview with Richard Godfrey, BerGenBio - Part of the NameTag Series - Update
  • Interview with Pawel Przewiezlikowski, Ryvu - Part of the Name Tag Series
  • Interview with David Parkinson, ESSA Pharma - Part of the Name Tag Series
  • Interview with Lucy Lu, Kintor Pharmaceutical - Part of the Name Tag Series
  • Scoop: SR One crew completes a complicated spinout from GlaxoSmithKline. And now they have a $500M fund to invest on their own
  • Michelle Levine joined Solasta Ventures in Boston as an Associate
  • Ronald Hsu left Artican Partners
  • CityWire - Star healthcare PM named next Wellington CEO
  • Interview with Theresa Heah, Asclepix - Part of the NameTag Series
  • Interview with Alex Zapesochny, Clerio Vision - Part of the NameTag Series
  • Interview with Vishal Doshi, AUM Biosciences - Part of the NameTag Series
  • Interview with Niquette Hunt, Candesant - Part of the NameTag Series
  • Interview with Zach Hornby, Boundless Bio - Part of the NameTag Series
  • Interview with Bob Geho, Diasome - Part of the NameTag Series
  • Interview with Bill Enright, Vaccitech - Part of the NameTag Series
  • Interview with Richard Andrews, Azitra - Part of the NameTag Series
  • Listen to Panels from our European Biotech Investor Day 2020
  • Life Sci VC - The Record-Breaking Biotech Funding Tsunami Of 1H2020
  • A new venture fund amid a pandemic? In the Nordics? Eir Ventures brings it on with €76M first close
  • SEC Proposes Amendments to Update Form 13F for Institutional Investment Managers; Amend Reporting Threshold to Reflect Today’s Equities Markets
  • OrbiMed Alum Maps Biotech Push
  • EndpointNews - The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
  • Slanix Alex, Pharm.D. left Consonance Capital Management LP
  • Derek Yuan left QUAD Investments
  • Filed S-1/A: Vaxcyte Launches 14mm Share IPO with $14-$16 Marketing Range
  • Filed S-1/A: Avidity Biosciences Launches 10mm Share IPO with $14-$16 Marketing Range
  • Filed S-1/A: Generation Bio Launches 7.4mm Share IPO with $16-$18 Marketing Range
  • IPO Filings - 4 Offerings
  • Endpoints - Atlas raises new $400M fund amid spree of VC raises. Here’s what they’ll spend it on
  • Forma Therapeutics File $150mm IPO
  • Repare Therapeutics File $100mm IPO
  • Check out the latest podcast in the NameTag series with Takashi Kei Kishimoto from Selecta Bio
  • Filed S-1/A: Pliant Therapeutics Launches 6mm Share IPO with $14-$16 Marketing Range
  • Generation Bio File $125mm IPO
  • Avidity Biosciences File $100mm IPO
  • Filed S-1/A: Inari Medical Launches 7.3mm Share IPO with $14-$16 Marketing Range
  • Interview with Melissa Epperly, Zentalis - Part of the NameTag Series

© Copyright 2023 by Solebury Strategic Communications | Current user: n/a, [en_US] | Privacy Policy